SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.

Keskin, Ali Umit; Bolukcu, Sibel; Ciragil, Pinar; Topkaya, Aynur Eren

Keskin, Ali Umit; Bolukcu, Sibel; Ciragil, Pinar; Topkaya, Aynur Eren.

Keskin AU; Department of Biomedical Engineering, Yeditepe University, Kayisdagi, Istanbul, Turkey.
Bolukcu S; Department of Infectious Diseases, Yeditepe University Kozyatagi Hospital, Istanbul, Turkey.
Ciragil P; Department of Clinical Microbiology, Yeditepe University Kozyatagi Hospital, Istanbul, Turkey.
Topkaya AE; Department of Clinical Microbiology, Yeditepe University Kozyatagi Hospital, Istanbul, Turkey.

J Med Virol ; 94(1): 39-41, 2022 01.

Article in English | MEDLINE | ID: covidwho-1427137

Subject(s)

Antibodies, Neutralizing/blood; Antibodies, Viral/blood; COVID-19 Vaccines/immunology; Immunization, Secondary/methods; SARS-CoV-2/immunology; Vaccines, Inactivated/immunology; Adult; BNT162 Vaccine; COVID-19/prevention & control; Coronavirus Nucleocapsid Proteins/immunology; Health Personnel; Humans; Immunoglobulin G/blood; Phosphoproteins/immunology; Spike Glycoprotein, Coronavirus/immunology; Turkey

Keywords

COVID-19; SARS-CoV-2; booster dose; immune response; inactive virus vaccine; mRNA vaccine; nucleocapsid antibody (IgG-N); spike antibody (IgG-S)

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Inactivated / Immunization, Secondary / Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / Antibodies, Viral Topics: Vaccines Limits: Adult / Humans Country/Region as subject: Asia Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27350

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google